A Randomized, Double-blind, Double-dummy, 4-week Treatment, Parallel-group Study to Evaluate the Efficacy and Safety of Two Doses of Mometasone Furoate Delivered Via Concept1 or Twisthalera(R) in Adult and Adolescent Patients With Persistent Asthma.
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Mometasone (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 10 Jun 2017 Biomarkers information updated
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Mar 2013 Planned End Date changed from 1 Feb 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.